Related Experiment Videos
Transgenic models for the study of endothelin function in the cardiovascular system
1Institute of Clinical Pharmacology and Toxicology, Free University Berlin, Germany.
Insights
Understanding cardiovascular disease requires studying the endothelin system. This review covers transgenic models used to investigate endothelin
Area of Science:
- Cardiovascular Physiology and Pathophysiology
- Endothelin System Biology
- Transgenic Model Development
Background:
- Cardiovascular diseases (CVDs) are a leading cause of mortality globally.
- Understanding CVD pathogenesis is crucial for developing effective treatments.
- The endothelin system is implicated in the development of cardiovascular diseases.
Purpose of the Study:
- To review existing transgenic models of the endothelin system.
- To highlight recent advancements in transgenic endothelin research.
- To provide insights into dissecting pathophysiological factors in CVDs.
Main Methods:
- Investigation of classical pharmacological and molecular biological approaches.
- Utilizing specific animal models for cardiovascular research.
- Development and application of novel transgenic methods for gene function studies.
Main Results:
- Several transgenic models with gain or loss of function strategies have been established for endothelin system components.
- These models facilitate the dissection of pathophysiological factors influencing CVD development.
- Evidence supports a significant role for the endothelin system in CVD pathogenesis.
Conclusions:
- Transgenic models are valuable tools for studying the endothelin system in cardiovascular disease.
- Further research using these models can deepen our understanding of CVD.
- Advancements in transgenic technology are crucial for future cardiovascular research.
Abstract:
Cardiovascular diseases are a major cause of mortality in our society. The development of a new successful treatment strategy requires a deeper understanding of cardiovascular physiology and pathophysiology. This can be achieved by using classical pharmacological and molecular biological approaches as well as by the investigation of specific animal models. In this context novel transgenic methods can be used to dissect pathophysiological factors influencing the development of cardiovascular disease. Because there is direct and indirect evidence for an important role of the endothelin system in the pathogenesis of cardiovascular diseases, several transgenic models with gain of function or loss of function strategies have been established for selected components of the endothelin system. This paper summarizes existing models and outlines recent developments in the transgenic field of endothelin research.